Alberto Tommasini
Alberto Tommasini has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Ventura
University of Trieste, trieste, Italy
3 shared publications - Loredana Lepore
University of Trieste, trieste, Italy
2 shared publications Alberto Burlina
Dipartimento di Pediatria, Università di Padova, Padua, Italy
1 shared publication- Andrea Taddio
Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy
1 shared publication - Antonella Insalaco
Ospedale Pediatrico Bambino Gesù IRCCS, ERN‐RITA Center
1 shared publication - Carlo De Pieri
Department of Medicine, Division of Pediatrics, University Hospital of Udine, Udine, Italy
1 shared publication
Latest Publications
- 16 April 2015
- Vol. 33 (3) , 437-42
Different presentations of mevalonate kinase deficiency: a case series.
We aimed to raise awareness among paediatricians and physicians about this often misunderstood condition. We discussed the clinical profiles associated with late or wrong diagnosis of mevalonate kinase deficency (MKD) in a single centre case series. We analysed the most common challenges and pitfalls that a clinician might face during the diagnostic process. Five main clinical profiles were characterised. We propose a new perspective on MKD, suggesting that the presentation of this disease can vary from patient to patient.
- 16 April 2015
- Vol. 33 (3) , 437-42
Different presentations of mevalonate kinase deficiency: a case series.
We aimed to raise awareness among paediatricians and physicians about this often misunderstood condition. We discussed the clinical profiles associated with late or wrong diagnosis of mevalonate kinase deficency (MKD) in a single centre case series. We analysed the most common challenges and pitfalls that a clinician might face during the diagnostic process. Five main clinical profiles were characterised. We propose a new perspective on MKD, suggesting that the presentation of this disease can vary from patient to patient.
- 1 January 2005
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 22 (2) , 147-151
AMANTADINE IN CHRONIC GRANULOMATOUS DISEASE
Chronic granulomatous disease (CGD) is a rare genetically determined immunodeficiency. Neutrophils from CGD patients show a defective killing of phagocytosed fungi and bacteria, due not only to an impairment in oxidative burst, but also to absence of normal pH value within phagocytic vacuole following phagocytosis. Because a weak base such as amantadine could potentially reverse these pH abnormalities, the authors used this drug to treat 2 CGD patients. They observed modifications of both phagosomal pH and killing activity on their neutrophils compared to those of healthy controls. Since the drug has been employed, the patients have not developed new infections, suggesting a role of amantadine as a part of CGD prophylactic regimen. These results suggest the opportunity of testing the drug in larger studies.
- 1 January 2005
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 22 (2) , 147-151
AMANTADINE IN CHRONIC GRANULOMATOUS DISEASE
Chronic granulomatous disease (CGD) is a rare genetically determined immunodeficiency. Neutrophils from CGD patients show a defective killing of phagocytosed fungi and bacteria, due not only to an impairment in oxidative burst, but also to absence of normal pH value within phagocytic vacuole following phagocytosis. Because a weak base such as amantadine could potentially reverse these pH abnormalities, the authors used this drug to treat 2 CGD patients. They observed modifications of both phagosomal pH and killing activity on their neutrophils compared to those of healthy controls. Since the drug has been employed, the patients have not developed new infections, suggesting a role of amantadine as a part of CGD prophylactic regimen. These results suggest the opportunity of testing the drug in larger studies.
- Open Access
- 1 October 2004
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (10) , 1856-1860
Anti-Transglutaminase Antibodies and Age
- 1 October 2004
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (10) , 1856-1860
Open AccessAnti-Transglutaminase Antibodies and Age